Global Irritable Bowel Syndrome (IBS) Competitive Landscape Professional Research Report 2024

Global Irritable Bowel Syndrome (IBS) Competitive Landscape Professional Research Report 2024

Research Summary

Irritable Bowel Syndrome (IBS) is a common gastrointestinal disorder characterized by a combination of symptoms, including abdominal pain, bloating, changes in bowel habits, and discomfort. IBS is considered a functional gastrointestinal disorder, meaning there is no structural abnormality or damage to the digestive tract. The exact cause of IBS is not well understood, but factors such as abnormalities in the gut-brain axis, hypersensitivity of the intestines, and changes in gut motility may contribute to its development. IBS can be categorized into different subtypes based on predominant symptoms, such as IBS with constipation (IBS-C), IBS with diarrhea (IBS-D), or mixed-type (alternating between constipation and diarrhea). Diagnosis is typically based on the presence of characteristic symptoms, and healthcare providers may recommend dietary changes, medications, and lifestyle modifications to manage symptoms. Although IBS can be a chronic condition, it does not lead to serious complications or increase the risk of other gastrointestinal diseases. Management strategies are focused on alleviating symptoms and improving the quality of life for individuals with IBS.

According to DIResearch's in-depth investigation and research, the global Irritable Bowel Syndrome (IBS) market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Irritable Bowel Syndrome (IBS) include Bausch Health, Allergan, Takeda, Sucampo Pharmaceuticals (Mallinckrodt), Sebela Pharmaceuticals Inc, Astellas Pharmaceuticals etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Irritable Bowel Syndrome (IBS). Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Irritable Bowel Syndrome (IBS) market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Irritable Bowel Syndrome (IBS) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Irritable Bowel Syndrome (IBS) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Irritable Bowel Syndrome (IBS) Include:

Bausch Health

Allergan

Takeda

Sucampo Pharmaceuticals (Mallinckrodt)

Sebela Pharmaceuticals Inc

Astellas Pharmaceuticals

Irritable Bowel Syndrome (IBS) Product Segment Include:

IBS-D Drug

IBS-C Drug

Others

Irritable Bowel Syndrome (IBS) Product Application Include:

Women

Men

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Irritable Bowel Syndrome (IBS) Industry PESTEL Analysis

Chapter 3: Global Irritable Bowel Syndrome (IBS) Industry Porter’s Five Forces Analysis

Chapter 4: Global Irritable Bowel Syndrome (IBS) Major Regional Market Size and Forecast Analysis

Chapter 5: Global Irritable Bowel Syndrome (IBS) Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Irritable Bowel Syndrome (IBS) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Irritable Bowel Syndrome (IBS) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Irritable Bowel Syndrome (IBS) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Irritable Bowel Syndrome (IBS) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Irritable Bowel Syndrome (IBS) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Irritable Bowel Syndrome (IBS) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Irritable Bowel Syndrome (IBS) Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources